Laboratory medicine has travelled a remarkable journey, from conventional monocular microscopy and biochemical testing by graduated mouth pipettes to automation, molecular diagnostics, digital pathology, and artificial intelligence. Better internet connectivity, cameras in our pockets, mobile devices, and AI tools such as ChatGPT and Claude have brought information and technical assistance within easy reach, even for smaller laboratories. Yet, this progress has also increased our responsibilities. In an era of evidence-based medicine, adopting new technology requires scientific validation, professional judgment, and the courage to take ownership of our decisions.
The real challenge begins when technological progress meets the economics of running a laboratory. Sophisticated instruments, expensive reagents, maintenance, quality assurance, logistics, and trained manpower have steadily increased operating costs. At the same time, diagnostic chains and online aggregators have intensified price competition through discounted packages and high-volume business models. When investigations are judged primarily by their price, the investment required for qualified staff, reliable reporting, and quality assurance is often overlooked.
Reagent-rental arrangements have made advanced instruments accessible without substantial initial investment – simultaneously building a stringent pressure among these giants to acquire greater volumes of patient samples at any cost. However, commitments to purchase reagents can create long-term commercial dependence. Many modern instruments cater to large volumes, leaving smaller laboratories with limited affordable options despite their important role in serving local cohorts.
The shortage of competent manpower is another serious concern. The mushrooming of educational institutions with variable teaching standards raises questions about the practical skills of some graduates entering the workforce. A degree or diploma cannot substitute for hands-on training, technical competence, and an understanding of laboratory quality. The problem is compounded by the difficulty of recruiting and retaining trained personnel.
Remuneration has become an increasingly sensitive issue. Laboratory professionals shoulder responsibility for diagnostic accuracy, quality control, critical-result communication, regulatory compliance and, frequently, emergency availability. Yet concerns about stagnant salaries, lower offers in some settings, and increasing workloads are widely voiced. When comparable opportunities in delivery services and the gig economy appear to offer more attractive earnings or predictable working conditions, retaining trained personnel becomes difficult. A profession requiring years of education and specialized expertise cannot remain sustainable if responsibility and remuneration drift too far apart.
The younger generation also places greater value on fixed working hours, work-life balance, and clearly defined responsibilities. These expectations are legitimate, and a big reason why freshly licensed professionals are opting for corporate jobs in favor of becoming an entrepreneur or private practitioner. The challenge is to maintain emergency coverage and continuity of laboratory services through better staffing, fair compensation, and sensible work arrangements rather than depending on the personal sacrifice of individual professionals.
Regulatory compliance adds another layer of pressure. Depending on the jurisdiction and establishment, laboratories may have to navigate accreditation guidelines, ISO standards, licenses, country specific taxation obligations, and other requirements. Quality and patient safety must never be compromised, but overlapping paperwork, inconsistent enforcement, and disproportionate costs can make life particularly difficult for small laboratories. Any substantiated instance of arbitrary or improper conduct by officials further weakens the confidence. Regulation should be transparent, proportionate, and uniformly implemented.
Quality does not begin and end with the analyzers. Errors may arise anywhere from pre- to post-analytics. Even the most sophisticated instrument cannot compensate for a poorly collected specimen or an incorrectly communicated report. Laboratory quality must therefore cover the entire testing process, from the test request to the final clinical decision.
Digitalization has brought its own responsibilities. Electronic reports, mobile applications, cloud-based systems, and interconnected health records improve access. But they also raise concerns about patient confidentiality, cybersecurity, and data sharing. Data-protection frameworks such as India's Digital Personal Data Protection Act 2023 make responsible handling of patient information increasingly important. Similarly, AI-assisted morphology, digital pathology, and automated decision support require appropriate validation and human oversight. Technology should assist the pathologist, not dilute professional accountability.
Another concern is the apparent mismatch, in some regions, between the number of testing facilities and the availability of appropriately qualified and registered laboratory medicine professionals. The extent varies across states, but the principle remains clear: expansion of diagnostic services must be accompanied by adequate supervision, competence, and accountability.
The solution does not lie in asking every small laboratory to compete with large chains on every front. Shared reference-testing facilities, pooled procurement, common training, collective quality-assurance programs, reliable referral networks, and coordinated logistics can reduce costs while preserving local access. Professional associations, regulators, educational institutions, and industry must work together to make quality diagnostics both accessible and economically sustainable for private practitioners as well.
Laboratory medicine must embrace innovation, but it cannot afford to lose sight of its purpose. If rising costs, workforce shortages, price competition, and inadequate professional recognition continue unchecked, patients may ultimately face reduced access, higher costs, and delays in diagnosis.
The future of laboratory medicine will not be determined by the sophisticated instrumentation and large volume testing. It will depend on whether we can sustain the professionals, institutions, and ethical standards that make an accurate diagnosis possible. Otherwise, we may leave the next generation with more advanced machines but fewer dependable diagnostic services.
Technology should be chosen for clinical need and training must put practical competence first. Regulators should be fair and accountable, and industry should treat instruments and reagents as part of healthcare, not only as a sales opportunity.
For us, every blood sample is a precious patient, not just a sample.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
